Serum neuron specific enolase: A marker for neuronal dysfunction in children with continuous EEG epileptiform activity

European Journal of Paediatric Neurology

Volumn 2, Issue 4, 1998, Pages 193-197

  O'Regan, M E ^a   Brown, J K ^a  

^a ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

Continuous epileptiform activity; Dementia; Non convulsive status epilepticus; Serum neuron specific enolase

Indexed keywords

NEURON SPECIFIC ENOLASE;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; DEMENTIA; ELECTROENCEPHALOGRAM; EPILEPTIC DISCHARGE; EPILEPTIC STATE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL;

EID: 0031714112     PISSN: 10903798     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1090-3798(98)80019-6     Document Type: Article

References (24)

1. Livingston JH, Brown JK. Diagnosis and management of non-convulsive status epilepticus. Paediatr Rev Commun 1988; 2: 283-315.
2. Binnie CD, Kasteleijn-Nolst T, Smit AM, Wilkins AJ. Interaction of epileptiform EEG discharge and cognition. Epilepsy Res 1987; 1: 239-245.
3. Livingston S, Torres I, Pauli LL. Petit mal epilepsy. Results of prolonged follow up study of 117 patients. J Am Med Assoc 1965; 194: 227-232.
4. Stores G. Psychological aspects of non-convulsive status epilepticus in children. J Child Psychol Psychiatr 1986; 27: 575-582.
5. Royds JA, Aelwyn G, Davies-Jones B, Lewtas NA, Timperley WR, Taylor CB. Enolase isoenzymes in the cerebrospinal fluid of patients with diseases of the nervous system. J Neurol Neurosurg Psychiatr 1983; 46: 1031-1036.
6. Roinie R, Somer H, Kaste M, Viinikka L, Karonen S. Neurological outcome after out of hospital cardiac arrest. Prediction by spinal fluid analysis. Arch Neurol 1989; 46: 753-756.
7. Ko F, Chiang C, Wu C, Wu L. Studies of neuron specific enolase in serum and cerebrospinal fluid of children with neurological diseases. Kaoshiung J Med Sci 1990 6: 137-143.
8. Steinberg R, Gueniau C, Scarna H. Experimental brain ischaemia: neuron specific enolase level in cerebrospinal fluid as an index of neuronal damage. J Neurochem 1984; 43: 19-24.
9. Hatfield R, McKernan R. CSF neuron specific enolase as a quantitative marker of neuronal damage in a rat stroke model. Brain Res 1992; 577: 249-252.
10. Karkela J, Bock E, Kaukinen S. CSF and serum brain specific creatine kinase isoenzyme (CK-BB), neuron specific enolase (NSE) and neural cell adhesion molecule (NCAM) as prognostic markers for hypoxic brain injury after cardiac arrest in man. J Neurol Sci 1993; 116: 100-109.
11. DeGiorgio CM, Correale JD, Gott PS, Ginsburgh DL, Bracht KA, Smith TS. Serum neuron specific enolase in human status epilepticus. Neurology 1995; 45: 1134-1137.
12. DeGiorgio CM, Rabinowicz AL, Gott PS, Smith TD, Heck CN, Correale JD. Neuron specific enolase, a marker of acute neuronal injury, is increased in complex partial status epilepticus. Epilepsia 1996; 37: 606-609.
13. Marangos PJ, Schmechel DE. Neuron specific enolase a clinically useful marker for neurons and neuroendocrine cells. Ann Rev Neurosci 1987; 10: 269-295.
14. Brotherstone R. The threatening silence of nocturnal seizures. J Electrophysiol Technol 1992; 18: 245-283.
15. Livingston JH, Brown JK, Harkness RA, McCreanor GM. Cerebrospinal fluid nucleotides metabolites following non-convulsive status. Develop Med Child Neurol 1989; 31: 168-173.
16. Saija A, Princi P, Pisani SA, Santoro R, De Pasquale R et al. Blood brain barrier dysfunction following systemic injection of kainic acid in the rat. Life Sci 1992; 51: 467-477.
17. Mihaly A, Bozoky B. Immunohistochemical localisation of extravasated serum albumin in the hippocampus of human subjects with partial or generalised epilepsies and epileptiform convulsions. Acta Neuropathol 1984; 65: 25-34.
18. Rabinowizc Al, Correale J, Boutros RB, Couldwell WT, Henderson CW, Degiorgio CM. Neuron specific enolase after single seizures during inpatient video/ EEG monitoring. Epilepsia 1996; 37: 122-125.
19. O'Regan ME, Brown JK, Goodwin GM, Clarke M. Epileptic aphasia a consequence of regional hypometabolism. Develop Med Child Neurol 1998 (in press).
20. Ferrie CD, Marsden PK, Maisey MN, Robinson RO. Cortical and sub-cortical glucose metabolism in childhood epileptic encephalopathies. Neurol Neurosurg Psychiatr 1997; 63: 181-187.
21. Harkness RA. Is post hypoxic ischemic cell damage associated with excessive ATP consumption rather than a failure of ATP production? Acta Paediatr 1997; 86: 1-5.
22. Dwyer BE, Wasterlain CG, Fujikawa DG, Yamada L. Brain protein metabolism synthesis in epilepsy. Adv Neurol 1986; 44: 903-918.
23. Wasterlain C. Inhibition of cerebral protein synthesis by epileptic seizures without motor manifestations. Neurology 1974; 24: 175-180.
24. Cendes F, Andermann Dubeau F, Matthews PM, Arnold DL. Normalization of neuronal metabolic function after surgery for temporal lobe epilepsy. Neurology 1997; 49: 1525-1533.